Načítá se...
Liposomal Bupivacaine as a Single-Injection Peripheral Nerve Block: A Dose-Response Study
BACKGROUND: Currently available local anesthetics approved for single-injection peripheral nerve blocks have a maximum duration less than 24 hours. A liposomal bupivacaine formulation (EXPAREL(®), Pacira Pharmaceuticals, Inc., San Diego, California), releasing bupivacaine over 96 hours, recently gai...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3808480/ https://ncbi.nlm.nih.gov/pubmed/24108252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1213/ANE.0b013e31829cc6ae |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|